Andrew Okun Sells 2,273 Shares of PerkinElmer, Inc. (PKI) Stock

PerkinElmer, Inc. (NYSE:PKI) insider Andrew Okun sold 2,273 shares of the stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $77.86, for a total transaction of $176,975.78. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Andrew Okun also recently made the following trade(s):

  • On Friday, December 15th, Andrew Okun sold 12,680 shares of PerkinElmer stock. The stock was sold at an average price of $72.00, for a total transaction of $912,960.00.

Shares of PerkinElmer, Inc. (PKI) traded down $1.82 during trading hours on Thursday, hitting $73.95. 402,643 shares of the company’s stock were exchanged, compared to its average volume of 715,151. PerkinElmer, Inc. has a 52 week low of $53.16 and a 52 week high of $84.49. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.90 and a current ratio of 1.27. The stock has a market cap of $8,150.00, a P/E ratio of 52.45, a PEG ratio of 1.76 and a beta of 0.76.

PerkinElmer (NYSE:PKI) last posted its earnings results on Thursday, January 25th. The medical research company reported $0.97 EPS for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.03. The firm had revenue of $641.63 million for the quarter, compared to the consensus estimate of $619.14 million. PerkinElmer had a net margin of 12.97% and a return on equity of 13.30%. The company’s revenue was up 13.2% on a year-over-year basis. During the same period last year, the firm posted $0.83 EPS. research analysts expect that PerkinElmer, Inc. will post 3.52 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 10th. Investors of record on Friday, April 13th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date of this dividend is Thursday, April 12th. PerkinElmer’s dividend payout ratio (DPR) is 19.86%.

A number of brokerages have commented on PKI. Robert W. Baird reissued a “buy” rating and issued a $88.00 price objective on shares of PerkinElmer in a research report on Friday, January 26th. Barclays increased their price objective on shares of PerkinElmer from $69.00 to $73.00 and gave the company an “underweight” rating in a research report on Friday, January 26th. Cowen reissued a “hold” rating and issued a $84.00 price objective on shares of PerkinElmer in a research report on Friday, January 26th. Zacks Investment Research raised shares of PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 price objective on the stock in a research report on Monday, January 8th. Finally, Evercore ISI began coverage on shares of PerkinElmer in a research report on Wednesday, January 3rd. They issued an “in-line” rating and a $77.00 price objective on the stock. One analyst has rated the stock with a sell rating, nine have given a hold rating and six have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $76.85.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Sentry Investment Management LLC grew its position in shares of PerkinElmer by 1.0% in the 2nd quarter. Sentry Investment Management LLC now owns 8,025 shares of the medical research company’s stock valued at $547,000 after buying an additional 78 shares during the last quarter. Mutual of America Capital Management LLC grew its position in shares of PerkinElmer by 3.5% in the 2nd quarter. Mutual of America Capital Management LLC now owns 13,470 shares of the medical research company’s stock valued at $918,000 after buying an additional 450 shares during the last quarter. Comerica Bank grew its position in shares of PerkinElmer by 3.0% in the 4th quarter. Comerica Bank now owns 26,881 shares of the medical research company’s stock valued at $2,189,000 after buying an additional 772 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its position in shares of PerkinElmer by 53.8% in the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 2,228 shares of the medical research company’s stock valued at $170,000 after buying an additional 779 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in shares of PerkinElmer by 9.6% in the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,963 shares of the medical research company’s stock valued at $618,000 after buying an additional 788 shares during the last quarter. 90.98% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.com-unik.info/2018/02/08/andrew-okun-sells-2273-shares-of-perkinelmer-inc-pki-stock.html.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Insider Buying and Selling by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit